Posts by: admin

admin

Chris Comish serves as the Publisher of the website, and is responsible for directing the editorial focus as well as putting the finishing touches on many featured articles.

August 31, 2017

Accordant’s Gaucher Program Receives NCQA Disease Management Accreditation

News

Accordant’s health programs, including its Gaucher disease program, have received a special Disease Management (DM) Accreditation from the National Committee for Quality Assurance (NCQA). NCQA is a non-profit organization that ... Read more

August 24, 2017

Cerdelga Trial Extension Confirms Improvements in Gaucher Type 1 Patients

News

Gaucher disease type 1 (GD1) patients who continued Cerdelga (eliglustat) treatment in an extension study confirmed general organ improvement. The results of a Phase 3 trial extension were reported in ... Read more

July 18, 2016

Study Identifies Promising Molecule for Therapy of Gaucher, Parkinson’s Diseases

News

National Institutes of Health researchers found a molecule that might one day be used as a treatment for Gaucher and Parkinson’s diseases. The research paper, “A New Glucocerebrosidase Chaperone Reduces ... Read more

July 13, 2016

Yale Case Study Indicates Gaucher Disease Patients May Be at Higher Risk for Skeletal Tumors

News

According to a recent case study and literature review from Yale University School of Medicine, people with Gaucher disease (GD) could be at higher risk for skeletal tumors. The report, ... Read more

June 7, 2016

Extension Study of Velaglucerase Alfa for Gaucher Disease Confirms Safety and Effectiveness

News

A new study from Japan shows promise for enzyme replacement therapy with velaglucerase alfa as a treatment for Gaucher disease. The report, “A multicenter, open-label extension study of velaglucerase alfa in ... Read more

May 19, 2016May 19, 2016

Ambroxol Seen to Ease Neurological Symptoms of Gaucher Disease in Pilot Study

News

An initial study from Japan demonstrated that oral ambroxol may help treat forms of Gaucher disease characterized by neurological symptoms. The study, “Ambroxol chaperone therapy for neuronopathic Gaucher disease: A pilot study,“ was published in ... Read more

May 18, 2016May 19, 2016

Type I Interferon, a Protein, Linked to Neuroinflammation in Gaucher Disease in Animal Study

News

A study by an international group of researchers in Israel, the U.S., and Germany indicates that type I interferon may contribute to Gaucher disease, specifically in a subset characterized by neuroinflammation. The report, “Induction ... Read more

May 11, 2016May 11, 2016

Scientists’ Discovery of Way of Tracking Key Enzyme May Aid in Treating Gaucher Disease

News

Scientists in the Netherlands have made a discovery that may advance the treatment of the genetic disorder known as Pompe disease. Along with co-workers in England, they found a possible blocker to ... Read more